Flow Cytometry Market Size Analysis, Industry Outlook, & Region Forecast, 2031

Posted by sneha j on July 12th, 2022

The flow cytometry market share is growing steadily in recent years, owing to rapid technological advancements, increase in investments in research & development and its extensive application in research & diagnostics. Further, wide scope of applications in different fields, increasing demands for advanced medical facilities, and increase in incidences of diseases such as cancer and HIV majorly supplement growth of in the global flow cytometry market. Alternatively, high costs of flow cytometry procedures and lack of awareness & trained personnel are key factors are expected to hamper the flow cytometry market size.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

• Agilent Technologies, Inc.
• Becton Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Miltenyi Biotec, Inc.
• Sartorius AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/90

On the basis of technology, the bead-based flow cytometry segment is expected to exhibit the fastest growth, registering a CAGR of 8.6% from 2022 to 2031, owing to flow cytometry market trends like wide scale use of technology in research field, lesser time consumption, and simultaneous analysis of multiple samples. However, the cell-based flow cytometry segment is the highest revenue generating segment, owing to its wide scale application in the diagnosis of various diseases such as cancer and HIV, biomedical research, and its increasing use in monitoring the progress of drug treatment.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/flow-cytometry-market

North America accounted for the highest revenue in the flow cytometry market in 2021. According to the flow cytometry market forecast, the market growth in the North America is supplemented by rapid technological advancements, increase in investments in research & development activities, rise in patent pool, and rise in the number of applications. However, Asia-Pacific is expected to emerge as the leading region, by registering a CAGR of 9.6% during the forecast period. This is mainly attributed to major international companies outsourcing their research processes to contract research organizations (CROs) located in Asia-Pacific. Moreover, impending need for sophisticated healthcare facilities and rise in incidences of chronic diseases such as HIV and cancer is expected to boost the market growth.